Robert W Georgantas, Katie Streicher, Steven A Greenberg, Lydia M Greenlees, Wei Zhu, Philip Z Brohawn, Brandon W Higgs, Meggan Czapiga, Christopher A Morehouse, Anthony Amato, Laura Richman, Bahija Jallal, Yihong Yao, Koustubh Ranade
OBJECTIVE: The molecular basis of inflammatory myopathies such as dermatomyositis (DM), polymyositis, and inclusion body myositis, which share the characteristics of chronic muscle inflammation and skeletal muscle wasting, are poorly understood. As such, effective targeted treatments for these diseases are lacking, resulting in critical unmet medical needs for these devastating diseases. The purpose of this study was to identify possible new targets for drug development by exploring the mechanism by which inflammation may play a role in the pathology of the inflammatory myopathies...
April 2014: Arthritis & Rheumatology